<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04413604</url>
  </required_header>
  <id_info>
    <org_study_id>19.08.INF</org_study_id>
    <nct_id>NCT04413604</nct_id>
  </id_info>
  <brief_title>Micronutrient Status in Children Aged 1-5 Years Consuming Their Habitual Diet With or Without Young Children's Milk</brief_title>
  <official_title>Micronutrient Status in Children Aged 1-5 Years Consuming Their Habitual Diet With or Without Young Children's Milk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates changes in Vitamin D, Zinc, and Iron status of children consuming 2&#xD;
      servings / day of the investigational (test) young children's milk (YCM) for 16 weeks&#xD;
      compared to children of the same age who consume their habitual pattern of beverage intake&#xD;
      for the same duration.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2021</start_date>
  <completion_date type="Anticipated">March 28, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in Vitamin D, Zinc or Iron status</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure blood vitamin D, Zinc and Iron value</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess micronutrient intake</measure>
    <time_frame>16 weeks</time_frame>
    <description>Using 24 hour dietary recall</description>
  </secondary_outcome>
  <other_outcome>
    <measure>assess other nutrient biomarkers</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure changes by blood measurement for CRP in mg/L</description>
  </other_outcome>
  <other_outcome>
    <measure>assess other nutrient biomarkers</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure changes by blood measurement for serum retinol in μmol/L</description>
  </other_outcome>
  <other_outcome>
    <measure>assess other nutrient biomarkers</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure changes by blood measurement for alpha(1)-acid glycoprotein in absolute value</description>
  </other_outcome>
  <other_outcome>
    <measure>assess child developmental milestones</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure Ages &amp; Stages Questionnaires, Third Edition; Minimum 0, Maximum 60, higher scores indicate more positive outcomes</description>
  </other_outcome>
  <other_outcome>
    <measure>assess child developmental milestones</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure Ages &amp; Stages Questionnaires: Social-Emotional, Second Edition, Minimum 0, Maximum 180, lower scores indicate more positive outcomes</description>
  </other_outcome>
  <other_outcome>
    <measure>assess bone mass index</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure the development of bone mass</description>
  </other_outcome>
  <other_outcome>
    <measure>assess gastrointestinal (GI) tolerance</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure changes in gut comfort level min 10, max 60. Lower score indicate more positive outcomes</description>
  </other_outcome>
  <other_outcome>
    <measure>assess YCM acceptability in children consuming GUM.</measure>
    <time_frame>16 weeks</time_frame>
    <description>measure how well acceptable is YCM for interventional group, minimum score 5 max score 33. higher score indicate positive outcome</description>
  </other_outcome>
  <other_outcome>
    <measure>To monitor growth and development</measure>
    <time_frame>16 weeks</time_frame>
    <description>Anthropometry Assessment based on BMI in (kg/m^2) by weight (Kilograms), height (Metres)</description>
  </other_outcome>
  <other_outcome>
    <measure>To monitor standard adverse events (AE)</measure>
    <time_frame>16 weeks</time_frame>
    <description>safety assessment by monitoring the AEs linked with participation in study</description>
  </other_outcome>
  <other_outcome>
    <measure>To monitor absenteeism from day care or pre-school due to illness</measure>
    <time_frame>16 weeks</time_frame>
    <description>safety assessment by monitoring the days of absenteeism linked with participation in study</description>
  </other_outcome>
  <other_outcome>
    <measure>To monitor concomitant medication (CM) reporting</measure>
    <time_frame>16 weeks</time_frame>
    <description>safety assessment by monitoring the concomitant medication linked with participation in study</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Nutritional Status</condition>
  <condition>Child Nutrition Sciences</condition>
  <arm_group>
    <arm_group_label>YCM Group (1- &lt;3) Years old</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 servings / day of the investigational (test) young children's milk (YCM) for 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation Group (1-&lt;3) Years old</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Habitual diet, consume the same regular foods and drinks as the children would normally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>YCM Group (3-5) Years old</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 servings / day of the investigational (test) young children's milk (YCM) for 16 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation Group (3-5) Years old</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Habitual diet, consume the same regular foods and drinks as the children would normally</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Young children's milk (1-&lt;3)</intervention_name>
    <description>young children's milk containing protein, energy and fat and micronutrients, in accordance with global and local nutritional recommendations for ages 1-3.</description>
    <arm_group_label>YCM Group (1- &lt;3) Years old</arm_group_label>
    <other_name>YCM</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Young children's milk (3-5)</intervention_name>
    <description>young children's milk containing protein, energy and fat and micronutrients, in accordance with global and local nutritional recommendations for ages 3-5.</description>
    <arm_group_label>YCM Group (3-5) Years old</arm_group_label>
    <other_name>YCM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent has been obtained from the parent.&#xD;
&#xD;
          -  Full-term gestational birth (≥ 37 completed weeks of gestation), with a birth weight&#xD;
             of ≥ 2.5 kg and ≤ 4.5 kg.&#xD;
&#xD;
          -  Child is age 12 - 32 months or 36 - 56 months at enrolment.&#xD;
&#xD;
          -  Child is no longer being breastfed (neither exclusively nor partially)&#xD;
&#xD;
          -  Child's parent is of legal age of consent, must understand the informed consent form&#xD;
             and other study documents, and is willing and able to fulfill the requirements of the&#xD;
             study protocol.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Child has consumed micronutrient supplements or micronutrient fortified foods or&#xD;
             beverages in amounts greater than the thresholds below:&#xD;
&#xD;
               1. Micronutrient supplements (except for vitamin A): zero in the past 4 weeks&#xD;
&#xD;
               2. Micronutrient-fortified foods or beverages: zero servings in the past 2 weeks&#xD;
&#xD;
          -  Chronic infectious illness, helminthiasis, or other acute disease/disorder potentially&#xD;
             affecting feeding or growth (mild infectious illness, such as acute viral&#xD;
             rhinopharyngitis, is acceptable).&#xD;
&#xD;
          -  Any congenital malformation (e.g., gastrointestinal tract atresia) or surgery sequelae&#xD;
             (e.g. short bowel syndrome) potentially affecting feeding, growth, or nutrient&#xD;
             absorption.&#xD;
&#xD;
          -  Child exhibits any clinical signs of potential micronutrient deficiencies (e.g.,&#xD;
             hemoglobin &lt; 100 g/L based on screening assessment, rickets based on physical exam).&#xD;
&#xD;
          -  Known or suspected cows' milk protein intolerance / allergy, lactose intolerance, soy&#xD;
             intolerance / allergy, fish oil intolerance / allergy, or other food allergies that&#xD;
             affect diet.&#xD;
&#xD;
          -  Child fed vegan, vegetarian, or vegetarian plus fish diets in which milk products are&#xD;
             excluded.&#xD;
&#xD;
          -  Weight-for-age value &lt; -2 or &gt; 2 standard deviations from the WHO(world health&#xD;
             organization) Child Growth Standards median at enrollment.&#xD;
&#xD;
          -  Height-for-age &lt; -2 or &gt; 2 standard deviations from the WHO(world health organization)&#xD;
             Child Growth Standards median at enrollment.&#xD;
&#xD;
          -  Child has participated in another clinical trial within 4 weeks prior to enrollment.&#xD;
&#xD;
          -  Child of any investigational site staff member or Nestle employee directly involved in&#xD;
             the conduct of the trial.&#xD;
&#xD;
          -  Other medical or psychiatric condition that, in the judgement of the investigator,&#xD;
             would make the child inappropriate for entry into the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>56 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Leslie Tan</last_name>
    <phone>91907756</phone>
    <email>leslie.tan@rdsg.nestle.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Indonesian Nutrition Association</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Saptawati Bardosono, PHD</last_name>
      <phone>0817 149 629</phone>
    </contact>
    <investigator>
      <last_name>Sudigdo Sastroasmoro, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Saptawati Bardosono, PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 27, 2020</study_first_submitted>
  <study_first_submitted_qc>May 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>February 18, 2021</last_update_submitted>
  <last_update_submitted_qc>February 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

